Veru Inc. ( VERU) - Key Metrics
VERU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | -$0.05 | -$0.05 | -$0.05 |
VERU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -2.27 |
VERU Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -18.63% | ? |
| 2026Q1 | -14.19% | ? |
| 2025Q4 | -9.86% | ? |
| 2025Q3 | -6.43% | ? |
| 2025Q2 | -10.79% | ? |
VERU
Price: $2.95
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.1 million
Ebitda: -7.3 millionMarket Capitalization: 54.6 million